The Outcome of Salvage Liver Transplantation and Liver Resection for Recurrent Hepatocellular Carcinoma Using the 5-5-500 Rule, Japanese Extended Liver Transplantation Criteria for Hepatocellular Carcinoma

被引:1
|
作者
Hirata, Yoshihiro [1 ,3 ]
Kotera, Yoshihito [1 ]
Kato, Takaaki [1 ]
Ariizumi, Syunichi [1 ]
Kogiso, Tomomi
Tokushige, Katsutoshi [2 ]
Honda, Goro [1 ]
Egawa, Hiroto [1 ]
机构
[1] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Hepatobiliary Pancreat Surg, Shinjuku Ku, Tokyo, Japan
[2] Tokyo Womens Med Univ, Inst Gastroenterol, Shinjuku Ku, Tokyo, Japan
[3] Tokyo Womens Med Univ, 8-1, Kawada Cho,Shinjuku Ku, Tokyo 1628666, Japan
关键词
REPEAT HEPATECTOMY; TUMOR SIZE; IMPACT;
D O I
10.1016/j.transproceed.2023.04.028
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Liver transplantation (LT) for hepatocellular carcinoma (HCC) is limited to Child-Pugh class C patients according to the Japanese HCC treatment algorithm. However, extended criteria of LT for HCC, known as the 5-5-500 rule, were published in 2019. Hepatocellular carcinoma reportedly has a high recurrence rate after primary treatment. We hypothesized that the outcome of recurrent HCC would be improved if the 5-5-500 rule were adopted for patients with recurrent HCC. We, therefore, analyzed the outcomes of surgical treatment (liver resection [LR] and LT) for recurrent HCC using the 5-5-500 rule in our institute.Methods. Fifty-two patients younger than 70 years of age received surgical treatment for recurrent HCC using our institute's 5-5-500 rule from 2010 to 2019. We divided these patients into the LR and LT groups in the first study. The 10-year overall survival and re-recurrence-free survival were analyzed. The second study analyzed the risk factors of re-recurrence after surgical treatment for recurrent HCC.Results. In the first study, the background characteristics of the 2 groups (LR and LT) showed no significant difference, except for age and Child-Pugh classification. There was no significant difference in the overall survival between groups (P = .35), but the re-recurrence-free survival in the LR group was significantly shorter than that in the LT group (P < .01). In the second study, the male sex and LR were risk factors of re-recurrence after surgical treatment for recurrent HCC. Child-Pugh's class did not contribute to re-recurrence. Conclusions. To improve the outcomes of recurrent HCC, LT is the better choice, regardless of the Child-Pugh class.
引用
收藏
页码:901 / 905
页数:5
相关论文
共 50 条
  • [21] Evolving Indications for Liver Transplantation for Hepatocellular Carcinoma Following the Milan Criteria
    Kokudo, Takashi
    Kokudo, Norihiro
    CANCERS, 2025, 17 (03)
  • [22] Liver transplantation for hepatocellular carcinoma: the Baylor experience
    Onaca, Nicholas
    Klintmalm, Goran B.
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2010, 17 (05) : 559 - 566
  • [23] Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma
    Pinna, Antonio Daniele
    Yang, Tian
    Mazzaferro, Vincenzo
    De Carlis, Luciano
    Zhou, Jian
    Roayaie, Sasan
    Shen, Feng
    Sposito, Carlo
    Cescon, Matteo
    Di Sandro, Stefano
    He Yi-feng
    Johnson, Philip
    Cucchetti, Alessandro
    ANNALS OF SURGERY, 2018, 268 (05) : 868 - 875
  • [24] Laparoscopic repeat liver resection for recurrent hepatocellular carcinoma
    Goh, Brian K. P.
    Teo, Jin-Yao
    Chan, Chung-Yip
    Lee, Ser-Yee
    Cheow, Peng-Chung
    Chung, Alexander Y. F.
    ANZ JOURNAL OF SURGERY, 2017, 87 (10) : E143 - E146
  • [25] Liver resection versus liver transplantation for hepatocellular carcinoma within the Milan criteria based on estimated microvascular invasion risks
    Yang, Pinghua
    Teng, Fei
    Bai, Shilei
    Xia, Yong
    Xie, Zhihao
    Cheng, Zhangjun
    Li, Jun
    Lei, Zhengqing
    Wang, Kui
    Zhang, Baohua
    Yang, Tian
    Wan, Xuying
    Yin, Hao
    Shen, Hao
    Pawlik, Timothy M.
    Lau, Wan Yee
    Fu, Zhiren
    Shen, Feng
    GASTROENTEROLOGY REPORT, 2023, 11
  • [26] Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma
    Unek, Tarkan
    Karademir, Sedat
    Arslan, Naciye Cigdem
    Egeli, Tufan
    Atasoy, Gulsen
    Sagol, Ozgul
    Obuz, Funda
    Akarsu, Mesut
    Astarcioglu, Ibrahim
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (37) : 4206 - 4212
  • [27] Liver Transplantation Selection and Allocation Criteria for Hepatocellular Carcinoma: A European Perspective
    Moeckli, Beat
    Majno, Pietro
    Orci, Lorenzo A.
    Peloso, Andrea
    Toso, Christian
    SEMINARS IN LIVER DISEASE, 2021, 41 (02) : 172 - 181
  • [28] Predictor of outcome after living donor liver transplantation for patients with hepatocellular carcinoma beyond the Japan criteria
    Yonemura, Yusuke
    Yoshizumi, Tomoharu
    Inokuchi, Shoichi
    Kosai-Fujimoto, Yukiko
    Harada, Noboru
    Itoh, Shinji
    Toshima, Takeo
    Takeishi, Kazuki
    Yoshiya, Shohei
    Mori, Masaki
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2020, 4 (04): : 413 - 421
  • [29] Liver Resection Versus Embolization for Recurrent Hepatocellular Carcinoma
    Midorikawa, Yutaka
    Takayama, Tadatoshi
    Moriguchi, Masamichi
    Yagi, Rempei
    Yamagishi, Shunsuke
    Nakayama, Hisashi
    Aramaki, Osamu
    Yamazaki, Shintaro
    Tsuji, Shingo
    Higaki, Tokio
    WORLD JOURNAL OF SURGERY, 2020, 44 (01) : 232 - 240
  • [30] Time of Hepatocellular Carcinoma Recurrence After Liver Resection and Alpha-Fetoprotein Are Important Prognostic Factors for Salvage Liver Transplantation
    Lee, Sanghoon
    Kwon, Choon Hyuck David
    Kim, Jong Man
    Joh, Jae-Won
    Paik, Seung Woon
    Kim, Bong-Wan
    Wang, Hee-Jung
    Lee, Kwang-Woong
    Suh, Kyung-Suk
    Lee, Suk-Koo
    LIVER TRANSPLANTATION, 2014, 20 (09) : 1057 - 1063